These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 26722525)
1. Expression of miR-203 is decreased and associated with the prognosis of melanoma patients. Wang K; Zhang ZW Int J Clin Exp Pathol; 2015; 8(10):13249-54. PubMed ID: 26722525 [TBL] [Abstract][Full Text] [Related]
2. Low Expression of Mir-137 Predicts Poor Prognosis in Cutaneous Melanoma Patients. Li N Med Sci Monit; 2016 Jan; 22():140-4. PubMed ID: 26763596 [TBL] [Abstract][Full Text] [Related]
3. MiR-330-5p regulates tyrosinase and PDIA3 expression and suppresses cell proliferation and invasion in cutaneous malignant melanoma. Su BB; Zhou SW; Gan CB; Zhang XN J Surg Res; 2016 Jun; 203(2):434-40. PubMed ID: 27363653 [TBL] [Abstract][Full Text] [Related]
4. Decreased serum microRNA-206 level predicts unfavorable prognosis in patients with melanoma. Tian R; Liu T; Qiao L; Gao M; Li J Int J Clin Exp Pathol; 2015; 8(3):3097-103. PubMed ID: 26045823 [TBL] [Abstract][Full Text] [Related]
5. Decreased expression of microRNA-20a promotes tumor progression and predicts poor prognosis of cutaneous squamous cell carcinoma. Zhang L; Xiang P; Han X; Wu L; Li X; Xiong Z Int J Clin Exp Pathol; 2015; 8(9):11446-51. PubMed ID: 26617873 [TBL] [Abstract][Full Text] [Related]
6. Decreased expression of miR-378 correlates with tumor invasiveness and poor prognosis of patients with glioma. Li B; Wang Y; Li S; He H; Sun F; Wang C; Lu Y; Wang X; Tao B Int J Clin Exp Pathol; 2015; 8(6):7016-21. PubMed ID: 26261592 [TBL] [Abstract][Full Text] [Related]
7. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma. Cai L; Cai X Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204 [TBL] [Abstract][Full Text] [Related]
8. Expression of microRNA-106b and its clinical significance in cutaneous melanoma. Lin N; Zhou Y; Lian X; Tu Y Genet Mol Res; 2015 Dec; 14(4):16379-85. PubMed ID: 26662433 [TBL] [Abstract][Full Text] [Related]
9. Down-regulated microRNA-124 expression as predictive biomarker and its prognostic significance with clinicopathological features in breast cancer patients. Arabkheradmand A; Safari A; Seifoleslami M; Yahaghi E; Gity M Diagn Pathol; 2015 Sep; 10():178. PubMed ID: 26415857 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma. Satzger I; Mattern A; Kuettler U; Weinspach D; Voelker B; Kapp A; Gutzmer R Int J Cancer; 2010 Jun; 126(11):2553-62. PubMed ID: 19830692 [TBL] [Abstract][Full Text] [Related]
11. IL-10Rα expression is post-transcriptionally regulated by miR-15a, miR-185, and miR-211 in melanoma. Venza I; Visalli M; Beninati C; Benfatto S; Teti D; Venza M BMC Med Genomics; 2015 Dec; 8():81. PubMed ID: 26631117 [TBL] [Abstract][Full Text] [Related]
12. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients. Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression. Mueller DW; Bosserhoff AK Int J Cancer; 2011 Sep; 129(5):1064-74. PubMed ID: 21077158 [TBL] [Abstract][Full Text] [Related]
14. MiR-431 is a prognostic marker and suppresses cell growth, migration and invasion by targeting NOTCH2 in melanoma. Sun YW; Li XH; Wang H; Wu J Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3876-3884. PubMed ID: 31115015 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-153 expression and prognosis in non-small cell lung cancer. Chen WJ; Zhang EN; Zhong ZK; Jiang MZ; Yang XF; Zhou DM; Wang XW Int J Clin Exp Pathol; 2015; 8(7):8671-5. PubMed ID: 26339455 [TBL] [Abstract][Full Text] [Related]
16. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma. Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796 [TBL] [Abstract][Full Text] [Related]
17. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi. Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773 [TBL] [Abstract][Full Text] [Related]
18. Prognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer. Sun X; Yang Z; Zhang Y; He J; Wang F; Su P; Han J; Song Z; Fei Y Int J Clin Exp Pathol; 2015; 8(7):8394-401. PubMed ID: 26339409 [TBL] [Abstract][Full Text] [Related]
19. Sensitive detection of melanoma metastasis using circulating microRNA expression profiles. Shiiyama R; Fukushima S; Jinnin M; Yamashita J; Miyashita A; Nakahara S; Kogi A; Aoi J; Masuguchi S; Inoue Y; Ihn H Melanoma Res; 2013 Oct; 23(5):366-72. PubMed ID: 23863473 [TBL] [Abstract][Full Text] [Related]
20. The Expression of miR-211-5p in Sentinel Lymph Node Metastases of Malignant Melanoma Is a Potential Marker for Poor Prognosis. Moritz RKC; Ebelt N; Rattay T; Ehrenreich J; Sunderkötter C; Gerloff D Int J Mol Sci; 2024 Oct; 25(19):. PubMed ID: 39409187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]